TK

Toshio Kaneko

Director Director DIN 01776129
DIN 01776129 First appointment Mar 2007 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2007
Shareholding value Locked Premium profile

About Toshio Kaneko

Data last updated:

Toshio Kaneko has 19 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01776129
Primary Designation Director
First Appointment 22 Mar 2007
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director22 Mar 20072007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eisai Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Toshio Kaneko

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Toshio Kaneko

Toshio Kaneko has 19 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

Toshio Kaneko is associated with 0 companies as a director.

Toshio Kaneko has expertise in General Business.

Toshio Kaneko has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available